Hypertension drives cardiovascular disease through maladaptive remodeling, with RAGE, Rap1a, and AngII interacting within a complex signaling network that promotes hypertrophy, inflammation, and fibrosis [4,5,6]. Here, AGER is linked to cardiovascular disorder.